GlassScriptPhysician profile
Christopher Curatolo
NPI 1285900100
$6,056.53
in general payments reported to CMS, 2019-2025
14 companies · $459 in 2025
The $459 reported for 2025 was more than what 90% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $575 · 2020: $324 · 2021: $516 · 2022: $2,164 · 2023: $712 · 2024: $1,307 · 2025: $459.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,477.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,647.29 | 2019-2025 | General - Pain Management, Superion Indirect Decompression System, Wavewriter Alpha Prime 16 |
| Nevro Corp. | $573.93 | 2019-2022 | |
| Vertos Medical, INC. | $319.57 | 2024 | Mild Device Kit |
| Abbott Laboratories | $297.59 | 2022-2024 | Eterna |
| Nalu Medical, INC. | $272.21 | 2022-2023 | Nalu Neurostimulation System |
| Spr Therapeutics, INC | $269.10 | 2023-2024 | Sprint Pns System |
| Saluda Medical Americas, INC. | $186.11 | 2024-2025 | Evoke |
| Pacira Pharmaceuticals Incorporated | $167.45 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $122.94 | 2019 | |
| Medtronic USA, INC. | $93.75 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $41.27 | 2025 | |
| Scilex Pharmaceuticals INC. | $26.40 | 2019 | |
| Lilly USA, LLC | $23.37 | 2019 | |
| Medtronic, INC. | $15.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Curatolo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.